. 2023 Mar 28;12(3):455–465. doi: 10.21037/tau-23-128

Table 1. Top 10 most active countries in targeted therapy for renal cancer as measured by the total number of publications from 2006 to 2022.

Ranking	Country	Number of documents	%
1^st	United States	366	32.21
2^nd	Italy	134	11.79
3^rd	China	131	11.53
4^th	Germany	106	9.33
5^th	France	99	8.71
6^th	England	87	7.65
7^th	Japan	69	6.07
8^th	Netherlands	62	5.45
9^th	Canada	59	5.19
10^th	Spain	57	5.01